Concepts (123)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
| Herpesvirus 4, Human | 2 | 2020 | 387 | 0.76 | Why? |
| Epstein-Barr Virus Infections | 2 | 2020 | 366 | 0.71 | Why? |
| Cytomegalovirus | 2 | 2019 | 600 | 0.63 | Why? |
| Cytomegalovirus Infections | 2 | 2019 | 667 | 0.58 | Why? |
| CD8-Positive T-Lymphocytes | 3 | 2021 | 5837 | 0.51 | Why? |
| Enzyme-Linked Immunospot Assay | 3 | 2021 | 325 | 0.42 | Why? |
| Antibodies, Neutralizing | 6 | 2021 | 25288 | 0.37 | Why? |
| Immunologic Memory | 1 | 2021 | 3362 | 0.37 | Why? |
| Vaccines, Synthetic | 1 | 2021 | 3231 | 0.36 | Why? |
| CD4-Positive T-Lymphocytes | 2 | 2021 | 4545 | 0.36 | Why? |
| Lupus Erythematosus, Systemic | 1 | 2019 | 1380 | 0.34 | Why? |
| Infectious Disease Transmission, Vertical | 2 | 2021 | 5164 | 0.32 | Why? |
| Antibodies, Viral | 6 | 2021 | 51949 | 0.30 | Why? |
| Immunoglobulin G | 5 | 2021 | 21571 | 0.25 | Why? |
| Immunoglobulin M | 1 | 2020 | 9091 | 0.24 | Why? |
| Microbial Viability | 2 | 2021 | 406 | 0.20 | Why? |
| Angiopoietin-2 | 1 | 2021 | 125 | 0.20 | Why? |
| T-Cell Antigen Receptor Specificity | 1 | 2019 | 93 | 0.19 | Why? |
| Antibodies, Bispecific | 1 | 2021 | 207 | 0.19 | Why? |
| Measles virus | 1 | 2018 | 194 | 0.16 | Why? |
| Vaccination | 2 | 2021 | 19050 | 0.16 | Why? |
| Seroepidemiologic Studies | 3 | 2021 | 10017 | 0.16 | Why? |
| Emergency Service, Hospital | 1 | 2020 | 14232 | 0.14 | Why? |
| Fomites | 1 | 2020 | 709 | 0.13 | Why? |
| Ozone | 1 | 2021 | 757 | 0.12 | Why? |
| Antigens, Viral | 2 | 2021 | 6298 | 0.12 | Why? |
| Cells, Cultured | 2 | 2021 | 5835 | 0.11 | Why? |
| Measles | 1 | 2018 | 608 | 0.11 | Why? |
| Immunity, Cellular | 2 | 2021 | 3614 | 0.11 | Why? |
| Communicable Diseases, Imported | 1 | 2018 | 843 | 0.10 | Why? |
| Italy | 5 | 2021 | 38444 | 0.10 | Why? |
| Blood Donors | 2 | 2021 | 2956 | 0.10 | Why? |
| Convalescence | 1 | 2021 | 2829 | 0.10 | Why? |
| Taste Disorders | 1 | 2021 | 1720 | 0.10 | Why? |
| Cross Reactions | 1 | 2021 | 4374 | 0.10 | Why? |
| Lymphocyte Activation | 1 | 2019 | 2742 | 0.09 | Why? |
| Interferon-gamma | 1 | 2019 | 2711 | 0.09 | Why? |
| Gene Expression Regulation | 1 | 2021 | 4020 | 0.09 | Why? |
| Pregnant Women | 1 | 2021 | 2535 | 0.09 | Why? |
| Viral Envelope Proteins | 1 | 2020 | 3539 | 0.09 | Why? |
| Arthritis, Rheumatoid | 1 | 2021 | 2043 | 0.09 | Why? |
| Disinfection | 1 | 2021 | 2912 | 0.08 | Why? |
| Young Adult | 5 | 2021 | 93724 | 0.08 | Why? |
| Cohort Studies | 2 | 2021 | 36005 | 0.08 | Why? |
| Serologic Tests | 1 | 2021 | 4359 | 0.08 | Why? |
| Antirheumatic Agents | 1 | 2021 | 3023 | 0.08 | Why? |
| Immunogenicity, Vaccine | 1 | 2021 | 4624 | 0.07 | Why? |
| Adult | 8 | 2021 | 244371 | 0.07 | Why? |
| Serine Endopeptidases | 1 | 2021 | 4606 | 0.07 | Why? |
| Humans | 19 | 2021 | 930598 | 0.07 | Why? |
| Female | 10 | 2021 | 380317 | 0.07 | Why? |
| Pregnancy Complications, Infectious | 2 | 2021 | 11559 | 0.06 | Why? |
| Olfaction Disorders | 1 | 2021 | 3704 | 0.06 | Why? |
| Middle Aged | 8 | 2021 | 270681 | 0.06 | Why? |
| Infant, Newborn | 2 | 2021 | 23105 | 0.06 | Why? |
| Betacoronavirus | 4 | 2020 | 204454 | 0.06 | Why? |
| Follow-Up Studies | 1 | 2021 | 17020 | 0.06 | Why? |
| Tertiary Care Centers | 1 | 2020 | 8248 | 0.06 | Why? |
| Aged, 80 and over | 3 | 2021 | 88759 | 0.06 | Why? |
| Prevalence | 2 | 2021 | 25773 | 0.06 | Why? |
| Pregnancy | 2 | 2021 | 23879 | 0.06 | Why? |
| Coinfection | 1 | 2021 | 6820 | 0.05 | Why? |
| Dependovirus | 1 | 2021 | 272 | 0.05 | Why? |
| Viral Load | 1 | 2020 | 15850 | 0.05 | Why? |
| Male | 7 | 2021 | 367725 | 0.05 | Why? |
| Pneumonia, Viral | 3 | 2020 | 243684 | 0.04 | Why? |
| Asia, Southeastern | 1 | 2018 | 390 | 0.04 | Why? |
| Coronavirus Infections | 3 | 2020 | 253789 | 0.04 | Why? |
| Methotrexate | 1 | 2021 | 471 | 0.04 | Why? |
| ROC Curve | 2 | 2021 | 6024 | 0.04 | Why? |
| Aged | 4 | 2021 | 215776 | 0.04 | Why? |
| Pandemics | 3 | 2020 | 389249 | 0.04 | Why? |
| Reverse Transcriptase Polymerase Chain Reaction | 3 | 2020 | 13720 | 0.04 | Why? |
| Adenoviridae | 1 | 2021 | 1151 | 0.04 | Why? |
| Body Weight | 1 | 2021 | 1074 | 0.04 | Why? |
| Opportunistic Infections | 1 | 2020 | 602 | 0.03 | Why? |
| Spike Glycoprotein, Coronavirus | 2 | 2021 | 37182 | 0.03 | Why? |
| Lymphocyte Subsets | 1 | 2020 | 987 | 0.03 | Why? |
| Infant, Newborn, Diseases | 1 | 2017 | 394 | 0.03 | Why? |
| Area Under Curve | 1 | 2021 | 2564 | 0.03 | Why? |
| Epitopes, B-Lymphocyte | 1 | 2021 | 1267 | 0.03 | Why? |
| Mice | 2 | 2021 | 21357 | 0.03 | Why? |
| Communicable Disease Control | 1 | 2021 | 29620 | 0.03 | Why? |
| Equipment Contamination | 1 | 2020 | 1308 | 0.03 | Why? |
| Real-Time Polymerase Chain Reaction | 2 | 2020 | 11367 | 0.03 | Why? |
| Coronavirus | 1 | 2020 | 18339 | 0.03 | Why? |
| Killer Cells, Natural | 1 | 2020 | 2093 | 0.03 | Why? |
| Immune Evasion | 1 | 2021 | 2081 | 0.03 | Why? |
| Mice, Inbred BALB C | 1 | 2021 | 5814 | 0.03 | Why? |
| Disease Outbreaks | 1 | 2018 | 27595 | 0.03 | Why? |
| Cluster Analysis | 1 | 2018 | 3001 | 0.03 | Why? |
| DNA, Viral | 1 | 2020 | 2521 | 0.03 | Why? |
| Mice, Inbred C57BL | 1 | 2021 | 5542 | 0.03 | Why? |
| Viral Matrix Proteins | 1 | 2017 | 1243 | 0.02 | Why? |
| Lymphocyte Count | 1 | 2020 | 4758 | 0.02 | Why? |
| Proportional Hazards Models | 1 | 2021 | 6543 | 0.02 | Why? |
| Phosphoproteins | 1 | 2017 | 4346 | 0.02 | Why? |
| Animals | 3 | 2021 | 78931 | 0.02 | Why? |
| Genotype | 1 | 2018 | 4697 | 0.02 | Why? |
| Neutralization Tests | 1 | 2020 | 6698 | 0.02 | Why? |
| Immunity, Humoral | 1 | 2021 | 4849 | 0.02 | Why? |
| Survival Rate | 1 | 2021 | 9206 | 0.02 | Why? |
| B-Lymphocytes | 1 | 2021 | 4418 | 0.02 | Why? |
| Glucocorticoids | 1 | 2021 | 4431 | 0.02 | Why? |
| Aerosols | 1 | 2021 | 5393 | 0.02 | Why? |
| Immunization, Passive | 1 | 2020 | 10067 | 0.02 | Why? |
| Intensive Care Units | 2 | 2020 | 29594 | 0.02 | Why? |
| T-Lymphocytes | 1 | 2021 | 6670 | 0.02 | Why? |
| Vero Cells | 1 | 2020 | 14117 | 0.02 | Why? |
| Clinical Laboratory Techniques | 2 | 2020 | 23402 | 0.02 | Why? |
| Disease Models, Animal | 1 | 2021 | 10998 | 0.02 | Why? |
| Interleukin-6 | 1 | 2021 | 7522 | 0.02 | Why? |
| Antibodies, Monoclonal | 1 | 2021 | 8041 | 0.01 | Why? |
| Viral Proteins | 1 | 2020 | 7370 | 0.01 | Why? |
| Incidence | 1 | 2021 | 25622 | 0.01 | Why? |
| Retrospective Studies | 2 | 2021 | 105322 | 0.01 | Why? |
| Biomarkers | 1 | 2021 | 23361 | 0.01 | Why? |
| Hospital Mortality | 1 | 2021 | 22087 | 0.01 | Why? |
| Risk Factors | 1 | 2021 | 71621 | 0.01 | Why? |
| Health Personnel | 1 | 2021 | 29646 | 0.01 | Why? |
| Hospitalization | 1 | 2021 | 54280 | 0.01 | Why? |
| Infection Control | 1 | 2018 | 23131 | 0.01 | Why? |
| Antiviral Agents | 1 | 2021 | 41703 | 0.01 | Why? |